ConvaTec Group PLC (CTEC) Receives “Buy” Rating from Goldman Sachs Group, Inc. (The)
Goldman Sachs Group, Inc. (The) reissued their buy rating on shares of ConvaTec Group PLC (LON:CTEC) in a research note issued to investors on Monday. They currently have a GBX 330 ($4.26) price target on the stock.
A number of other analysts have also issued reports on the stock. Deutsche Bank AG raised their target price on shares of ConvaTec Group PLC from GBX 330 ($4.26) to GBX 335 ($4.33) and gave the stock a buy rating in a research report on Monday, August 21st. Peel Hunt lifted their price target on shares of ConvaTec Group PLC from GBX 380 ($4.91) to GBX 390 ($5.04) and gave the company a buy rating in a report on Wednesday, August 9th. Numis Securities Ltd decreased their price target on shares of ConvaTec Group PLC from GBX 260 ($3.36) to GBX 250 ($3.23) and set a reduce rating on the stock in a report on Wednesday, August 9th. Finally, J P Morgan Chase & Co decreased their price target on shares of ConvaTec Group PLC from GBX 318 ($4.11) to GBX 303 ($3.91) and set an overweight rating on the stock in a report on Friday, August 4th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. The stock has a consensus rating of Buy and an average target price of GBX 311.78 ($4.03).
Shares of ConvaTec Group PLC (LON:CTEC) traded down 1.55% during mid-day trading on Monday, reaching GBX 267.60. The company’s stock had a trading volume of 3,930,202 shares. ConvaTec Group PLC has a 1-year low of GBX 213.00 and a 1-year high of GBX 349.10. The company’s market capitalization is GBX 5.22 billion. The firm’s 50 day moving average price is GBX 289.86 and its 200-day moving average price is GBX 293.95.
COPYRIGHT VIOLATION WARNING: This piece was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/09/12/convatec-group-plc-ctec-receives-buy-rating-from-goldman-sachs-group-inc-the.html.
The business also recently declared a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be issued a GBX 1.06 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a dividend yield of 0.36%.
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.